Drug
Levoleucovorin calcium clinical trials
Also written Isovorin.
A product of Levoleucovorin; its studies count on that page too.
Keep track of what changes. Save the levoleucovorin calcium studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2002 (2)
| Year | Studies |
|---|---|
| 2002 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2020 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 2
Southwest Autism Research & Resource Center (2) · Takeda (2) · Wyeth is now a wholly owned subsidiary of Pfizer (2)
Often tested with
Tested in the same studies.
Oxaliplatin (2) · Fluorouracil (2) · Panitumumab (2) · Bevacizumab (1)
Studies
Open first, then newest update. How each study uses levoleucovorin calcium is read from its arms, and is right about nine times in ten.
Testing it · 6
- Treatment of Social and Language Deficits With Leucovorin for Young Children With AutismRecruitingPhase 2Southwest Autism Research & Resource CenterNCT04060030Written as Levoleucovorin Calcium
- Early Treatment of Language Impairment in Young Children With Autism Spectrum Disorder With Leucovorin CalciumActive, not recruitingPhase 2Southwest Autism Research & Resource CenterNCT04060017Written as Levoleucovorin Calcium
- Panitumumab and RAS, Diagnostically-useful Gene Mutation for mCRCCompletedPhase 3TakedaNCT02394795Written as oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, panitumumab
- Safety and Efficacy Study of mFOLFOX6 + Panitumumab Combination Therapy and 5-FU/LV + Panitumumab Combination Therapy in Participants With Chemotherapy-naïve Unresectable Advanced Recurrent Colorectal CarcinomaCompletedPhase 2TakedaNCT02337946Written as oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, panitumumab
- Study Evaluating Isovorin in Advanced/Recurrent Gastric CancerCompletedPhase 3Wyeth is now a wholly owned subsidiary of PfizerNCT00195572Written as Isovorin
- Study Evaluating Isovorin in Colon CancerCompletedPhase 3Wyeth is now a wholly owned subsidiary of PfizerNCT00195585Written as Isovorin
Given in every arm · 8 — levoleucovorin calcium is usual care beside what is tested
- A Study of Olomorasib (LY3537982) in Participants With Advanced Colorectal Cancer and a KRAS G12C MutationNot yet recruitingPhase 2Eli Lilly and CompanyNCT07814417Written as Leucovorin/levofolinate calcium
- A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)RecruitingPhase 3Merck Sharp & Dohme LLCNCT06997497Written as Leucovorin/levofolinate calcium
- Study of ONO-4578 and XELOX/FOLFOX Plus Bevacizumab in Colorectal CancerActive, not recruitingPhase 1Ono Pharmaceutical Co., Ltd.NCT06547385Written as Calcium Levofolinate Hydrateb
- Study in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaBActive, not recruitingPhase 3Azienda USL Reggio Emilia - IRCCSNCT04776655Written as Calcium levofolinate
- Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal AdenocarcinomaCompletedPhase 1University Hospital, GrenobleNCT05546853Written as Calcium levofolinate
- Bevacizumab + Triplet Treatment for Untreated With Chemotherapy Metastatic Colorectal CancerCompletedPhase 2Translational Research Center for Medical Innovation, Kobe, Hyogo, JapanNCT02497157Written as Levofolinate calcium (l-LV)
- mFOLFOX Versus mFOLFIRI Versus FOLFPTX as First-line Treatment in AGC or EGJAStatus unknownNot applicableFujian Cancer HospitalNCT03045770Written as calcium levofolinate
- Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT TumorsTerminatedPhase 2Cliniques universitaires Saint-Luc- Université Catholique de LouvainNCT01858662Written as leucovorin L
As the comparator · 4 — what is tested is compared with levoleucovorin calcium
- A Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Biliary Tract Cancer After Platinum-containing Chemotherapy FailureRecruitingPhase 3Sichuan Baili Pharmaceutical Co., Ltd.NCT07606599Written as Calcium levofolinate
- A Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally Advanced or Metastatic Biliary Tract Cancer After Failure of Platinum-based Chemotherapy(PANKU-BTC01)RecruitingPhase 3Sichuan Baili Pharmaceutical Co., Ltd.NCT07582315Written as Calcium levofolinate
- Phase II of BAX2398/5-FU/Calcium Levofolinate in Pancreatic CancerCompletedPhase 2Institut de Recherches Internationales ServierNCT02697058Written as 5-FU/calcium levofolinate
- IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal CancerSuspendedPhase 3Hokkaido Gastrointestinal Cancer Study GroupNCT00316745Written as Isovorin
Codes
What other systems call levoleucovorin calcium · ClinicalTrials.gg INT015420
- RxNorm 979509One source FDA
- Wikidata Q11349901levoleucovorin calciumOne source Wikidata
- NCI Thesaurus C66721Levoleucovorin CalciumOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| RxNorm | 979509 | — | One source FDA |
| Wikidata | Q11349901 | levoleucovorin calcium | One source Wikidata |
| NCI Thesaurus | C66721 | Levoleucovorin Calcium | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.